Nitrogen

Description

NITROGEN, COMPRESSED NF UN1066 is a non-flammable gas with the chemical identification number CAS 7727-37-9.

Uses and Indications

This drug is indicated for use in specific medical situations where the administration of Nitrogen is deemed necessary. It is essential that this drug be administered only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of Use: The administration of Nitrogen may be hazardous or contraindicated in certain circumstances, and careful consideration must be given to the patient's condition and medical history prior to use.

There are no teratogenic or nonteratogenic effects associated with this drug as per the available data.

Dosage and Administration

For administration, Nitrogen is to be used exclusively by or under the supervision of a licensed practitioner experienced in its use and administration.

The route of administration is via respiratory inhalation. The active ingredient consists of Nitrogen, with a concentration of 990 mL in a 1 L volume.

Healthcare professionals should ensure that the administration is conducted in a controlled environment, adhering to established safety protocols and guidelines for inhalation therapies.

Contraindications

Use of this product is contraindicated in situations where contact with eyes, skin, or clothing may occur, as liquid exposure can lead to adverse effects. Additionally, the product should not be dropped; it is recommended to utilize a hand truck for container movement to prevent potential accidents or spills.

Warnings and Precautions

Administration of Nitrogen may pose significant hazards and is contraindicated in certain situations. It is imperative that this substance is used solely by or under the supervision of a licensed practitioner who possesses experience in the administration of Nitrogen. This practitioner must be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Nitrogen is contained under pressure and may explode if subjected to heat. Additionally, it has the potential to displace oxygen, leading to rapid suffocation. The liquid and gas forms of Nitrogen are extremely cold and can cause severe frostbite, as well as rapid suffocation.

General precautions must be strictly adhered to in order to ensure safe handling and use of Nitrogen. Prior to handling, all safety precautions should be thoroughly read and understood. Nitrogen should only be used and stored outdoors or in well-ventilated areas. A backflow preventive device must be utilized in the piping, and only equipment rated for cylinder pressure should be employed. It is essential to close the valve after each use and when the cylinder is empty. Protection from sunlight is necessary when ambient temperatures exceed 52 degrees Celsius (125 degrees Fahrenheit). The Safety Data Sheet (SDS) must be read and followed prior to use, and adequate ventilation should be maintained during storage and use. Care should be taken to avoid contact with liquid Nitrogen in the eyes, on the skin, or on clothing. When withdrawing liquid, appropriate personal protective equipment, including a face shield and gloves, should be worn. Containers should not be dropped; instead, a hand truck should be used for movement. All handling should be in accordance with the material Safety Data Sheet (MSDS).

In the event of inhalation, it is crucial to remove the affected individual to fresh air and ensure they are comfortable for breathing. Medical advice or attention should be sought immediately. In cases of frostbite, prompt medical treatment is necessary. If an individual is not breathing, artificial respiration should be administered, and if breathing is difficult, oxygen should be provided. A physician should be contacted without delay.

Side Effects

Patients may experience serious adverse reactions, including severe frostbite and rapid suffocation. These reactions have been reported in clinical settings and warrant immediate medical attention. It is crucial for healthcare providers to monitor patients closely for these serious events, as they can lead to significant morbidity.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Administration of Nitrogen in pediatric patients may pose significant risks and is contraindicated in certain situations. It is essential that Nitrogen is used only by or under the supervision of a licensed practitioner who has experience in its use and administration, particularly with pediatric considerations in mind.

Safety precautions are critical when administering Nitrogen to children. The substance may lead to rapid suffocation and severe frostbite, necessitating careful monitoring and adherence to safety protocols during its use in this population.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Administration of Nitrogen during pregnancy may pose risks and is contraindicated in certain situations. Pregnant patients should be aware that the use of Nitrogen is restricted to licensed practitioners who are experienced in its administration. The potential hazards associated with Nitrogen include the risk of rapid suffocation due to oxygen displacement, as well as the risk of explosion if the gas is heated.

Healthcare professionals should advise pregnant patients to adhere strictly to safety precautions, including using and storing Nitrogen only outdoors or in well-ventilated areas. It is essential to utilize back flow preventive devices in the piping and to ensure that all equipment is rated for cylinder pressure. After each use, the valve should be closed, and the gas should be protected from sunlight when ambient temperatures exceed 52 degrees C (125 degrees F).

In the event of inhalation, it is critical to remove the individual to fresh air and ensure they are comfortable for breathing, while seeking medical advice or attention. Additionally, in cases of frostbite, immediate medical treatment is necessary. For comprehensive safety and product information, healthcare professionals should refer to the Material Safety Data Sheet (SDS) prior to use.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established, and further research may be necessary to determine safety and efficacy in this population.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert for Nitrogen. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of guidance necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, intravenous fluids, and monitoring of vital parameters.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Consultation with a poison control center or toxicology expert may also be warranted to guide management decisions.

It is crucial to document all findings and interventions in the patient's medical record and to report any adverse events to the appropriate regulatory authorities as required.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to fully evaluate the nonclinical toxicology profile.

Postmarketing Experience

No specific postmarketing experience details are available in the extracted data. As such, there are no additional adverse events or rare case reports to summarize at this time.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrogen may pose hazards or be contraindicated. It is essential that Nitrogen is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Providers must emphasize the warning that Nitrogen contains gas under pressure, which may explode if heated. Additionally, it may displace oxygen and lead to rapid suffocation. Patients should be instructed not to handle Nitrogen until they have read and understood all safety precautions. It is crucial to use and store Nitrogen only outdoors or in a well-ventilated area.

Healthcare providers should inform patients about the importance of using a backflow preventive device in the piping and ensuring that all equipment is rated for cylinder pressure. Patients should be reminded to close the valve after each use and when the cylinder is empty. They should also protect the cylinder from sunlight when the ambient temperature exceeds 52 degrees Celsius (125 degrees Fahrenheit) and to read and follow the Safety Data Sheet (SDS) prior to use.

In case of inhalation, patients should be instructed to remove themselves to fresh air and maintain comfort for breathing. Medical advice or attention should be sought immediately. It is important to keep the container in an upright position at all times and to be aware that the liquid and gas are extremely cold and under pressure, which can cause rapid suffocation and severe frostbite.

Patients should be cautioned against getting the liquid in their eyes, on their skin, or on clothing. When withdrawing liquid, they should wear a face shield and gloves. Providers should advise against dropping the container and recommend using a hand truck for movement. Patients must use Nitrogen in accordance with the material Safety Data Sheet (MSDS).

In the event of frostbite, patients should seek medical treatment immediately. Healthcare providers should encourage patients to refer to the material Safety Data Sheet for comprehensive safety and product information.

Storage and Handling

The product is supplied in containers that must be stored and used exclusively outdoors or in well-ventilated areas. It is essential to protect the product from sunlight when the ambient temperature exceeds 52 degrees Celsius (125 degrees Fahrenheit). Containers should always be maintained in an upright position to ensure safety and integrity.

Adequate ventilation is required during both storage and use. When withdrawing the liquid, personnel must wear a face shield and gloves to prevent exposure. It is critical to avoid contact with eyes, skin, or clothing. After each use and when the container is empty, the valve should be securely closed.

Users are advised to follow the guidelines outlined in the Material Safety Data Sheet (MSDS) for safe handling practices. Additionally, care should be taken to avoid dropping the container; a hand truck should be utilized for any necessary movement of the container to prevent accidents.

Additional Clinical Information

The route of administration for the product is via respiratory inhalation. Clinicians should be aware that the administration of Nitrogen may pose hazards or contraindications and should only be performed by or under the supervision of a licensed practitioner experienced in its use. It is crucial for practitioners to be familiar with the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be counseled to read and understand all safety precautions before handling the product. It should be used and stored outdoors or in well-ventilated areas, and a backflow preventive device must be utilized in the piping. Equipment must be rated for cylinder pressure, and the valve should be closed after each use and when empty. Protection from sunlight is necessary when ambient temperatures exceed 52 degrees C (125 degrees F). In case of inhalation, individuals should be moved to fresh air and kept comfortable for breathing, and medical advice or attention should be sought.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by ILMO Products Company. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)